Journal rankings · indicator year 2011
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2011
Oncology journal rankings 2011
150 ranked journals · Subfield in Medicine
Oncology has 150 ranked journals in 2011. The median OJR fell 0.06 on 2010 to 0.95, below the world average of 1.00; Q1 starts at OJR 1.47. The top three are CA A Cancer Journal for Clinicians, Cancer Cell, and Journal of Clinical Oncology.
Ranks and citation indicators: 2011. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2008–2010, the window the 2011 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery570
- Pulmonary and Respiratory Medicine236
- Cardiology and Cardiovascular Medicine200
- Public Health, Environmental and Occupational Health192
- Oncology150
- Epidemiology139
- Infectious Diseases131
- Endocrinology, Diabetes and Metabolism111
- Neurology109
- Radiology, Nuclear Medicine and Imaging108
- Psychiatry and Mental health107
- Physiology104
Show all 42 subfields
- Orthopedics and Sports Medicine78
- Pediatrics, Perinatology and Child Health68
- Ophthalmology62
- Dermatology60
- Hematology59
- Rheumatology49
- Obstetrics and Gynecology48
- Nephrology41
- Complementary and alternative medicine36
- Pharmacology36
- Reproductive Medicine36
- Emergency Medicine30
- Geriatrics and Gerontology30
- Otorhinolaryngology28
- Pathology and Forensic Medicine21
- Rehabilitation20
- Critical Care and Intensive Care Medicine18
- Immunology and Allergy14
- Genetics12
- Hepatology12
- Urology11
- Anesthesiology and Pain Medicine8
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
150 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2010. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2008–2010, the window the 2011 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2008–2010 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2002 to 2011. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 43.03Q1 | 111.23 6.34 up from 2010 | 67 | 100% | $4,330 | ||
2Cancer CellCell Press · Netherlands | 7.01Q1 | 19.44 1.09 up from 2010 | 425 | 99% | $10,400 | ||
3Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 5.98Q1 | 14.92 0.85 up from 2010 | 3,323 | 10% | — | ||
4The Lancet OncologyElsevier BV · United Kingdom | 5.88Q1 | 14.18 1.50 up from 2010 | 693 | 15% | $7,280 | ||
5Nature MedicineNature Portfolio · United States | 5.23Q1 | 10.73 1.39 down from 2010 | 1,177 | 30% | $12,690 | ||
6JNCI Journal of the National Cancer InstituteOxford University Press · United States | 4.23Q1 | 10.18 1.01 down from 2010 | 677 | 42% | $5,436 | ||
7Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 3.56Q1 | 8.77 1.68 up from 2010 | 199 | 70% | — | ||
8Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 3.36Q1 | 9.00 0.53 up from 2010 | 2,843 | 64% | — | ||
9Seminars in Cancer BiologyElsevier BV · United States | 3.17Q1 | 6.75 2.34 down from 2010 | 160 | 31% | $6,060 | ||
10Clinical Pharmacology & TherapeuticsWiley · United States | 2.66Q1 | 5.16 0.24 up from 2010 | 792 | 20% | $4,410 | ||
11CancerWiley · United States | 2.66Q1 | 5.58 0.43 down from 2010 | 2,382 | 68% | $4,790 | ||
12The OncologistOAAlphaMed Press · United Kingdom | 2.52Q1 | 5.30 1.69 down from 2010 | 492 | 98% | $3,852 | ||
13Annals of OncologyElsevier BV · Netherlands | 2.50Q1 | 6.03 0.37 up from 2010 | 1,483 | 95% | $5,080 | ||
14Journal of Mammary Gland Biology and NeoplasiaSpringer Science+Business Media · United States | 2.47Q1 | 6.27 1.35 up from 2010 | 116 | 43% | $4,090 | ||
15Cancer Treatment ReviewsElsevier BV · United Kingdom | 2.32Q1 | 7.20 0.50 down from 2010 | 289 | 8% | $4,910 | ||
16British Journal of CancerSpringer Nature · United Kingdom | 2.31Q1 | 6.21 0.57 up from 2010 | 1,782 | 100% | $5,190 | ||
17Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 2.30Q1 | 6.22 0.22 up from 2010 | 1,099 | 18% | — | ||
18Current Opinion in OncologyLippincott Williams & Wilkins · United Kingdom | 2.29Q1 | 5.41 0.28 up from 2010 | 311 | 11% | — | ||
19European Journal of CancerElsevier BV · United Kingdom | 2.27Q1 | 6.00 0.44 up from 2010 | 1,225 | 4% | $4,270 | ||
20The Cancer JournalLippincott Williams & Wilkins · United States | 2.18Q1 | 4.41 0.52 up from 2010 | 245 | 38% | — | ||
21International Journal of CancerWiley · United States | 2.10Q1 | 5.54 0.51 up from 2010 | 2,463 | 73% | $5,030 | ||
22Cancer Prevention ResearchAmerican Association for Cancer Research · United States | 2.05Q1 | 5.03 0.27 down from 2010 | 462 | 41% | — | ||
23Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 2.00Q1 | 5.24 0.33 up from 2010 | 1,365 | 41% | — | ||
24Seminars in OncologyElsevier BV · United States | 1.99Q1 | 4.89 0.62 up from 2010 | 234 | 19% | $3,550 | ||
25Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.97Q1 | 5.07 0.51 up from 2010 | 485 | 13% | — | ||
26Cancer ControlOASAGE Publishing · United States | 1.91Q1 | 4.84 0.31 up from 2010 | 105 | 35% | $2,650 | ||
27Journal of Hematology & OncologyOABioMed Central · United Kingdom | 1.90Q1 | 5.29 1.40 up from 2010 | 129 | 100% | $4,990 | ||
28Current Treatment Options in OncologySpringer Science+Business Media · United States | 1.89Q1 | 3.83 0.26 up from 2010 | 75 | 13% | $4,890 | ||
29Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.87Q1 | 4.23 0.33 up from 2010 | 225 | 13% | $3,950 | ||
30Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 1.86Q1 | 4.10 0.78 down from 2010 | 347 | 8% | $4,190 | ||
31European Journal of EpidemiologySpringer Science+Business Media · Italy | 1.80Q1 | 4.62 0.14 down from 2010 | 312 | 57% | $3,690 | ||
32Diseases of the Colon & RectumLippincott Williams & Wilkins · United States | 1.71Q1 | 3.82 0.28 up from 2010 | 821 | 4% | — | ||
33Clinical & Experimental MetastasisSpringer Science+Business Media · Netherlands | 1.70Q1 | 3.77 1.06 down from 2010 | 222 | 32% | $5,090 | ||
34Journal of Cancer SurvivorshipSpringer Science+Business Media · United States | 1.63Q1 | 3.71 0.89 up from 2010 | 112 | 57% | $4,790 | ||
35Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.62Q1 | 3.47 0.38 up from 2010 | 710 | 15% | — | ||
36BMC CancerOABioMed Central · United Kingdom | 1.61Q1 | 4.06 0.03 up from 2010 | 1,556 | 100% | $3,390 | ||
37Psycho-OncologyWiley · United Kingdom | 1.52Q1 | 3.31 0.01 down from 2010 | 528 | 29% | $4,940 | ||
38Journal of Inorganic BiochemistryElsevier BV · United States | 1.47Q1 | 3.44 0.02 up from 2010 | 585 | 20% | $4,220 | ||
39Cancer Causes & ControlSpringer Science+Business Media · Netherlands | 1.47Q2 | 3.46 0.10 up from 2010 | 587 | 53% | $3,890 | ||
40Journal of ImmunotherapyLippincott Williams & Wilkins · United States | 1.45Q2 | 4.07 0.18 up from 2010 | 304 | 35% | — | ||
41MicrocirculationWiley · United States | 1.45Q2 | 2.99 0.41 down from 2010 | 191 | 42% | $3,920 | ||
42Breast Cancer ResearchOABioMed Central · United Kingdom | 1.44Q2 | 4.34 0.68 up from 2010 | 848 | 100% | $4,190 | ||
43Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.40Q2 | 4.06 0.15 down from 2010 | 498 | 100% | $4,590 | ||
44CytotherapyElsevier BV · United Kingdom | 1.38Q2 | 3.91 0.17 down from 2010 | 372 | 18% | $3,300 | ||
45JBIC Journal of Biological Inorganic ChemistrySpringer Science+Business Media · Germany | 1.34Q2 | 2.99 0.09 up from 2010 | 396 | 32% | $3,990 | ||
46Seminars in Oncology NursingElsevier BV · United States | 1.34Q2 | 1.93 0.20 down from 2010 | 95 | 9% | $3,590 | ||
47Supportive Care in CancerSpringer Science+Business Media · Germany | 1.34Q2 | 2.90 0.38 up from 2010 | 671 | 23% | $4,690 | ||
48Future OncologyFuture Medicine · United Kingdom | 1.31Q2 | 3.09 0.57 up from 2010 | 441 | 13% | — | ||
49JNCI MonographsOxford University Press · United Kingdom | 1.30Q2 | 3.32 0.42 down from 2010 | 61 | 83% | — | ||
50Current Oncology ReportsSpringer Science+Business Media · United States | 1.28Q2 | 3.52 0.88 up from 2010 | 207 | 12% | $5,090 |
Subfields of Medicine, with Oncology highlighted.
- Surgery570
- Pulmonary and Respiratory Medicine236
- Cardiology and Cardiovascular Medicine200
- Public Health, Environmental and Occupational Health192
- Oncology150
- Epidemiology139
- Infectious Diseases131
- Endocrinology, Diabetes and Metabolism111
- Neurology109
- Radiology, Nuclear Medicine and Imaging108
- Psychiatry and Mental health107
- Physiology104
- Orthopedics and Sports Medicine78
- Pediatrics, Perinatology and Child Health68
- Ophthalmology62
- Dermatology60
- Hematology59
- Rheumatology49
- Obstetrics and Gynecology48
- Nephrology41
- Complementary and alternative medicine36
- Pharmacology36
- Reproductive Medicine36
- Emergency Medicine30
- Geriatrics and Gerontology30
- Otorhinolaryngology28
- Pathology and Forensic Medicine21
- Rehabilitation20
- Critical Care and Intensive Care Medicine18
- Immunology and Allergy14
- Genetics12
- Hepatology12
- Urology11
- Anesthesiology and Pain Medicine8
- Gastroenterology6
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2011. Corpus-wide, 75.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
48 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2008–2010, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2011. Publication window: 2008–2010. How these summaries are calculated
- Ranked journals
- 150
- Window papers (baseline)
- 82,075 +24.2% from indicator year 2008
- Median OJR
- 0.95 +0.7% from indicator year 2008
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2008–2010 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.